Aloyz RS - Search Results

1

Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia.

Bello VE, Aloyz RS, Christodoulopoulos G, Panasci LC. Bello VE, et al. Among authors: aloyz rs. Biochem Pharmacol. 2002 May 1;63(9):1585-8. doi: 10.1016/s0006-2952(02)00954-1. Biochem Pharmacol. 2002. PMID: 12007561

2

The role of DNA repair in nitrogen mustard drug resistance.

Panasci L, Xu ZY, Bello V, Aloyz R. Panasci L, et al. Anticancer Drugs. 2002 Mar;13(3):211-20. doi: 10.1097/00001813-200203000-00002. Anticancer Drugs. 2002. PMID: 11984064 Review.

3

DNA repair protein levels vis-à-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program.

Xu Z, Chen ZP, Malapetsa A, Alaoui-Jamali M, Bergeron J, Monks A, Myers TG, Mohr G, Sausville EA, Scudiero DA, Aloyz R, Panasci LC. Xu Z, et al. Anticancer Drugs. 2002 Jun;13(5):511-9. doi: 10.1097/00001813-200206000-00010. Anticancer Drugs. 2002. PMID: 12045463

4

Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD.

Aloyz R, Xu ZY, Bello V, Bergeron J, Han FY, Yan Y, Malapetsa A, Alaoui-Jamali MA, Duncan AM, Panasci L. Aloyz R, et al. Cancer Res. 2002 Oct 1;62(19):5457-62. Cancer Res. 2002. PMID: 12359753

5

Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.

Xu ZY, Loignon M, Han FY, Panasci L, Aloyz R. Xu ZY, et al. J Pharmacol Exp Ther. 2005 Aug;314(2):495-505. doi: 10.1124/jpet.105.084053. Epub 2005 Apr 20. J Pharmacol Exp Ther. 2005. PMID: 15843498

6

Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase.

Amrein L, Loignon M, Goulet AC, Dunn M, Jean-Claude B, Aloyz R, Panasci L. Amrein L, et al. J Pharmacol Exp Ther. 2007 Jun;321(3):848-55. doi: 10.1124/jpet.106.118356. Epub 2007 Mar 9. J Pharmacol Exp Ther. 2007. PMID: 17351105

7

Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro.

Amrein L, Hernandez TA, Ferrario C, Johnston J, Gibson SB, Panasci L, Aloyz R. Amrein L, et al. Br J Haematol. 2008 Dec;143(5):698-706. doi: 10.1111/j.1365-2141.2008.07418.x. Br J Haematol. 2008. PMID: 19062342 Free article.

8

A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients.

Hebb J, Assouline S, Rousseau C, Desjardins P, Caplan S, Egorin MJ, Amrein L, Aloyz R, Panasci L. Hebb J, et al. Cancer Chemother Pharmacol. 2011 Sep;68(3):643-51. doi: 10.1007/s00280-010-1530-7. Epub 2010 Dec 1. Cancer Chemother Pharmacol. 2011. PMID: 21120481 Clinical Trial.

9

Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapy.

Amrein L, Davidson D, Shawi M, Petruccelli LA, Miller WH Jr, Aloyz R, Panasci L. Amrein L, et al. Leuk Res. 2011 Aug;35(8):1080-6. doi: 10.1016/j.leukres.2011.01.004. Epub 2011 Feb 1. Leuk Res. 2011. PMID: 21281966

10

Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.

Panasci L, Paiement JP, Christodoulopoulos G, Belenkov A, Malapetsa A, Aloyz R. Panasci L, et al. Clin Cancer Res. 2001 Mar;7(3):454-61. Clin Cancer Res. 2001. PMID: 11297233 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters